title: GADA testing: the current state of knowledge.
abstract: This review considers the current knowledge and practice of GADA testing people with diabetes in Europe and the UK. Important issues are raised, including interpretation of the results and the clinical relevance of the GADA titre. Recommendations are made towards standardising GADA testing, using World Health Organization units.
authors.affiliation: Centre for Health Information, Research and Evaluation [CHIRAL], The School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom. h.davies@swansea.ac.uk
authors.forename: H
authors.initials: H
authors.lastname: Davies
authors.forename: S
authors.initials: S
authors.lastname: Brophy
authors.forename: S C
authors.initials: SC
authors.lastname: Bain
authors.forename: J W
authors.initials: JW
authors.lastname: Stephens
authors.forename: J
authors.initials: J
authors.lastname: Lewis
authors.forename: S
authors.initials: S
authors.lastname: Luzio
authors.forename: G
authors.initials: G
authors.lastname: Dunseath
authors.forename: C
authors.initials: C
authors.lastname: Beaverstock
authors.forename: D R R
authors.initials: DR
authors.lastname: Williams
mesh_terms: D015415:Biomarkers / Q000097:blood; D003920:Diabetes Mellitus / Q000097:blood / Q000145:classification / Q000201:enzymology*; D005968:Glutamate Decarboxylase / Q000097:blood*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D012680:Sensitivity and Specificity
chemical_list: D015415:Biomarkers; D007004:Hypoglycemic Agents; D007328:Insulin; D005968:Glutamate Decarboxylase